RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $241,100 | – | 36,753 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,962,221 | $18,190,000 | 5.62% |
| RiverVest Venture Management LLC | 2,409,220 | $22,478,000 | 4.39% |
| Novo Holdings A/S | 3,430,377 | $32,005,000 | 1.42% |
| Aisling Capital Management LP | 886,075 | $8,267,000 | 1.32% |
| NEA Management Company, LLC | 4,786,921 | $44,662,000 | 0.58% |
| Prosight Management, LP | 54,934 | $513,000 | 0.32% |
| Rock Springs Capital Management LP | 1,129,024 | $10,534,000 | 0.21% |
| Pinz Capital Management, LP | 56,823 | $530,000 | 0.16% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 750,000 | $6,998,000 | 0.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 849,300 | $7,924,000 | 0.14% |